Ablation Technologies Worldwide Market, 2008-2017: Products, Technologies, Markets, Companies and Opportunities · 264 pages · 70 Exhibits · 61 Company Profiles · September 2008 · Report #A125 This report is a detailed market and technology assessment and forecast of the products and technologies in the ablation market for treatment of soft tissues via energy-based modalities, [...]
Following up on my post yesterday regarding ablation treatments for prostate cancer, one of the ablation modalities noted was HIFU, or high-intensity focused ultrasound. Unlike lasers, RF, microwave or cryotherapy, ultrasound offers superior control of energy output. 3D control and directionality of the energy delivered provides the ability to treat a prescribed target volume and shape [...]
Energy-based technologies and treatments exist for virtually all clinical specialties. Given the ability of these technologies, particularly ablation technologies, to very precisely destroy tissue, they have been strongly developed for cancer applications and much success has already been achieved in producing treatments that have low risk, short recovery times and good long term outcomes. Cost [...]
Manufacturers of ablation and other energy-base therapeutics are both witnessing and driving a steady evolution of multiple technologies with potential to produce therapeutic (or, in some cases, simply cosmetic) tissue effects, with different energy types competing head-on for caseload. These innovators have continued to improve their understanding of the nature of each energy type’s impact [...]
The world market for energy-based devices was well in excess of $25 billion in 2008. This represents almost 14% of the total medical device market; however, the share varies from country to country, since ablation therapy is high-technology and fairly high-cost; in poorer economies low-cost medical products such as syringes and consumables account for a [...]
Energy-based therapeutics include technologies to effect the destruction or treatment of tissues to remove pathology or otherwise modify tissue (e.g., for creating lesions that block the aberrant signals in arrhythmia). These technologies include radiofrequency, microwave, laser/light, microwave, cryo, hydromechanical, ultrasound and thermal. Some sectors of the energy-based market are growing steadily, others more rapidly. RF [...]
Medtronic is the predominant player in the energy-based therapies market. With global sales of nearly $4.9 billion attributable to energy-based products, it controls over half of the cardiac rhythm market and almost a quarter of all energy-based product sales. Boston Scientific, also focusing on cardiac arrhythmias, comes next in the revenues table with a $2. [...]
Contact:
